Research study Program year 2024 Source: CMS Open Payments

A Phase 3B, Multicenter, Single-Arm, Open-Label Study Evaluating the E

Research payments

$1,211,953

399 payments

Through program year 2024, $1,211,953 in research payments was reported against A Phase 3B, Multicenter, Single-Arm, Open-Label Study Evaluating the E, across 399 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2024	Research	$1,152,917	383
2023	Research	$59,037	16

Breakdown

Who paid Research payments · program years 2023–2024

GlaxoSmithKline, LLC. $1,211,953 399 payments

Who received the money Research payments · program years 2023–2024

Oregon Health And Science University Organisation paid for research $76,694 25 payments
Bios Clinical Research LLC Organisation paid for research $72,677 15 payments
Trustees Of The University Of Pennsylvania Organisation paid for research $67,539 8 payments
Accellacare US INC Organisation paid for research $67,232 27 payments
Biomedical Research Alliance Of New York LLC Organisation paid for research $61,498 20 payments
Whitman Walker Institute INC Organisation paid for research $61,405 14 payments
Medical College Of Georgia Organisation paid for research $52,961 18 payments
Unehealth Organisation paid for research $51,421 28 payments
The Moses H Cone Memorial Hospital Operating Corpo Organisation paid for research $43,420 6 payments
Midway Immunology And Research Organisation paid for research $42,631 13 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.